Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 13 |
GO:0042995 | cell projection | 2 | 13 |
GO:0043226 | organelle | 2 | 13 |
GO:0043227 | membrane-bounded organelle | 3 | 13 |
GO:0110165 | cellular anatomical entity | 1 | 13 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 13 |
Related structures:
AlphaFold database: E9B6L0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 129 | 133 | PF00656 | 0.525 |
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.243 |
CLV_NRD_NRD_1 | 194 | 196 | PF00675 | 0.697 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.415 |
CLV_NRD_NRD_1 | 294 | 296 | PF00675 | 0.423 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.279 |
CLV_NRD_NRD_1 | 72 | 74 | PF00675 | 0.230 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.254 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.496 |
CLV_PCSK_KEX2_1 | 294 | 296 | PF00082 | 0.432 |
CLV_PCSK_KEX2_1 | 64 | 66 | PF00082 | 0.320 |
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.269 |
CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.327 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.734 |
DEG_SPOP_SBC_1 | 170 | 174 | PF00917 | 0.583 |
DOC_CDC14_PxL_1 | 85 | 93 | PF14671 | 0.469 |
DOC_MAPK_gen_1 | 20 | 27 | PF00069 | 0.499 |
DOC_MAPK_gen_1 | 64 | 71 | PF00069 | 0.320 |
DOC_MAPK_MEF2A_6 | 39 | 46 | PF00069 | 0.488 |
DOC_PP4_FxxP_1 | 144 | 147 | PF00568 | 0.634 |
DOC_SPAK_OSR1_1 | 109 | 113 | PF12202 | 0.454 |
DOC_USP7_MATH_1 | 114 | 118 | PF00917 | 0.454 |
DOC_USP7_MATH_1 | 170 | 174 | PF00917 | 0.607 |
DOC_USP7_MATH_1 | 182 | 186 | PF00917 | 0.706 |
DOC_USP7_MATH_1 | 197 | 201 | PF00917 | 0.733 |
DOC_USP7_MATH_1 | 244 | 248 | PF00917 | 0.751 |
DOC_WW_Pin1_4 | 156 | 161 | PF00397 | 0.637 |
LIG_14-3-3_CanoR_1 | 13 | 22 | PF00244 | 0.399 |
LIG_14-3-3_CanoR_1 | 171 | 177 | PF00244 | 0.665 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.396 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.450 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.349 |
LIG_FHA_2 | 125 | 131 | PF00498 | 0.512 |
LIG_FHA_2 | 160 | 166 | PF00498 | 0.606 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.628 |
LIG_Integrin_isoDGR_2 | 211 | 213 | PF01839 | 0.745 |
LIG_LIR_Apic_2 | 143 | 147 | PF02991 | 0.529 |
LIG_LIR_Apic_2 | 149 | 154 | PF02991 | 0.536 |
LIG_LIR_Gen_1 | 258 | 266 | PF02991 | 0.596 |
LIG_LIR_Nem_3 | 104 | 110 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 258 | 262 | PF02991 | 0.653 |
LIG_LRP6_Inhibitor_1 | 71 | 77 | PF00058 | 0.288 |
LIG_MYND_3 | 88 | 92 | PF01753 | 0.453 |
LIG_PTAP_UEV_1 | 227 | 232 | PF05743 | 0.472 |
LIG_Rb_LxCxE_1 | 86 | 104 | PF01857 | 0.453 |
LIG_SH2_CRK | 151 | 155 | PF00017 | 0.695 |
LIG_SH2_CRK | 259 | 263 | PF00017 | 0.647 |
LIG_SH2_SRC | 233 | 236 | PF00017 | 0.608 |
LIG_SH3_3 | 225 | 231 | PF00018 | 0.719 |
LIG_SH3_3 | 263 | 269 | PF00018 | 0.671 |
LIG_SUMO_SIM_par_1 | 45 | 50 | PF11976 | 0.202 |
LIG_TRAF2_1 | 127 | 130 | PF00917 | 0.509 |
LIG_TRAF2_1 | 162 | 165 | PF00917 | 0.662 |
LIG_TRAF2_1 | 269 | 272 | PF00917 | 0.597 |
LIG_WRC_WIRS_1 | 141 | 146 | PF05994 | 0.642 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.715 |
MOD_CK1_1 | 216 | 222 | PF00069 | 0.630 |
MOD_CK1_1 | 247 | 253 | PF00069 | 0.708 |
MOD_CK1_1 | 261 | 267 | PF00069 | 0.669 |
MOD_CK1_1 | 283 | 289 | PF00069 | 0.496 |
MOD_CK2_1 | 124 | 130 | PF00069 | 0.367 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.661 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.742 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.756 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.669 |
MOD_GlcNHglycan | 215 | 218 | PF01048 | 0.665 |
MOD_GlcNHglycan | 228 | 231 | PF01048 | 0.543 |
MOD_GlcNHglycan | 266 | 269 | PF01048 | 0.657 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.684 |
MOD_GSK3_1 | 195 | 202 | PF00069 | 0.675 |
MOD_GSK3_1 | 260 | 267 | PF00069 | 0.744 |
MOD_LATS_1 | 193 | 199 | PF00433 | 0.606 |
MOD_N-GLC_2 | 26 | 28 | PF02516 | 0.353 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.369 |
MOD_NEK2_1 | 296 | 301 | PF00069 | 0.600 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.343 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.366 |
MOD_PIKK_1 | 172 | 178 | PF00454 | 0.468 |
MOD_PIKK_1 | 27 | 33 | PF00454 | 0.420 |
MOD_PKA_1 | 195 | 201 | PF00069 | 0.653 |
MOD_PKA_2 | 170 | 176 | PF00069 | 0.504 |
MOD_Plk_1 | 283 | 289 | PF00069 | 0.372 |
MOD_ProDKin_1 | 156 | 162 | PF00069 | 0.633 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.309 |
TRG_ENDOCYTIC_2 | 259 | 262 | PF00928 | 0.650 |
TRG_ER_diArg_1 | 107 | 109 | PF00400 | 0.299 |
TRG_ER_diArg_1 | 19 | 21 | PF00400 | 0.532 |
TRG_ER_diArg_1 | 293 | 295 | PF00400 | 0.432 |
TRG_ER_diArg_1 | 64 | 66 | PF00400 | 0.320 |
TRG_ER_diArg_1 | 71 | 73 | PF00400 | 0.320 |
TRG_NES_CRM1_1 | 17 | 31 | PF08389 | 0.391 |
TRG_NES_CRM1_1 | 33 | 45 | PF08389 | 0.359 |
TRG_Pf-PMV_PEXEL_1 | 124 | 128 | PF00026 | 0.460 |
TRG_Pf-PMV_PEXEL_1 | 64 | 68 | PF00026 | 0.304 |
TRG_Pf-PMV_PEXEL_1 | 77 | 81 | PF00026 | 0.349 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7V8 | Leptomonas seymouri | 32% | 100% |
A0A0N1IJM3 | Leptomonas seymouri | 61% | 99% |
A0A0S4JGU9 | Bodo saltans | 41% | 96% |
A0A1X0P674 | Trypanosomatidae | 48% | 96% |
A0A3S7X9J5 | Leishmania donovani | 89% | 100% |
A0A422N788 | Trypanosoma rangeli | 48% | 100% |
A4HMZ8 | Leishmania braziliensis | 76% | 100% |
A4IBM1 | Leishmania infantum | 89% | 100% |
C9ZZ14 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
E9AFF5 | Leishmania major | 89% | 100% |
V5DUQ3 | Trypanosoma cruzi | 49% | 100% |